140 related articles for article (PubMed ID: 37660035)
21. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis.
Zhi XH; Jiang K; Ma YY; Zhou LQ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in non-small cell lung cancer.
Qiao X; Zhao F
Bioengineered; 2022 Apr; 13(4):9264-9273. PubMed ID: 35411833
[TBL] [Abstract][Full Text] [Related]
23. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
Li L; Duan Z; Yu J; Dang HX
Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
[TBL] [Abstract][Full Text] [Related]
24. OIP5-AS1/miR-137/ZNF217 Axis Promotes Malignant Behaviors in Epithelial Ovarian Cancer.
Guo L; Chen J; Liu D; Liu L
Cancer Manag Res; 2020; 12():6707-6717. PubMed ID: 32801903
[TBL] [Abstract][Full Text] [Related]
25. OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling.
Zhang Q; Li X; Ren L; Gu X; Xiao N; Li N
Tissue Cell; 2023 Jun; 82():102082. PubMed ID: 37027968
[TBL] [Abstract][Full Text] [Related]
26. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
[TBL] [Abstract][Full Text] [Related]
27. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.
Wang L; Yan W; Li X; Liu Z; Tian T; Chen T; Zou L; Cui Z
J Ovarian Res; 2019 Nov; 12(1):113. PubMed ID: 31739800
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
[TBL] [Abstract][Full Text] [Related]
29. PUM1 promotes ovarian cancer proliferation, migration and invasion.
Guan X; Chen S; Liu Y; Wang LL; Zhao Y; Zong ZH
Biochem Biophys Res Commun; 2018 Feb; 497(1):313-318. PubMed ID: 29428722
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
Li J; Huang H; Li Y; Li L; Hou W; You Z
Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway.
Meng X; Ma J; Wang B; Wu X; Liu Z
J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498
[TBL] [Abstract][Full Text] [Related]
32. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model.
Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z
J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882
[TBL] [Abstract][Full Text] [Related]
33. The role of lncRNA OIP5-AS1 in cancer development and progression.
Zheng C; Chu M; Chen Q; Chen C; Wang ZW; Chen X
Apoptosis; 2022 Jun; 27(5-6):311-321. PubMed ID: 35316453
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancer.
Zhu M; Takano A; Tsevegjav B; Yoshitake Y; Shinohara M; Daigo Y
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35103287
[TBL] [Abstract][Full Text] [Related]
35. Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway.
Li HC; Chen YF; Feng W; Cai H; Mei Y; Jiang YM; Chen T; Xu K; Feng DX
Gene; 2017 Mar; 603():1-8. PubMed ID: 27916718
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K.
Geng L; Wang Z; Tian Y
J Ovarian Res; 2022 Jan; 15(1):1. PubMed ID: 34980214
[TBL] [Abstract][Full Text] [Related]
37. Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics.
Dong C; Tian X; He F; Zhang J; Cui X; He Q; Si P; Shen Y
J Ovarian Res; 2021 Jul; 14(1):92. PubMed ID: 34253236
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
[TBL] [Abstract][Full Text] [Related]
39. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]